Vision recovery similar at 30 days, consistent with other recent randomized studies ...

Once-daily carbachol/brimonidine tartrate significantly improves aging-related vision loss ...

Myra Vision has treated the first patient in its ADAPT clinical study evaluating the Calibreye TGT Surgical System in ...

Owner and Therapist, Neil Yust from Fyzical Therapy and Balance Centers shows us how vision can affect your balance and also ...

Myra Vision's Calibreye aqueous shunt for glaucoma patients is designed to provide adjustable and reversible outflow control.

Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in patients with glaucoma and NAION.

Billings, MT - January 26, 2026 - PRESSADVANTAGE - Patients seeking expert care for glaucoma in the region are turning ...

Opus Genetics launches gene therapy clinical trial for MERTK-related retinitis pigmentosa: Research Triangle Park, North Carolina Wednesday, January 28, 2026, 16:00 Hrs [IST] Opus ...

The MarketWatch News Department was not involved in the creation of this content.-- Initial case conducted by Dr. David Godfrey at Glaucoma Associates of Texas -- The IDE study wi ...

Actor turned rare disease advocate Luke Rosen tells how his daughter, Susannah, lives with a KIF1A-associated neurological ...

The trial will enrol up to 70 patients with refractory glaucoma and has a 12-month primary effectiveness endpoint.

The FDA granted orphan drug designation to OpCT-001 for the treatment of retinitis pigmentosa, according to a press release ...